Literature DB >> 25645515

Mutations in TAX1BP3 cause dilated cardiomyopathy with septo-optic dysplasia.

Eyal Reinstein1, Katia Orvin, Einav Tayeb-Fligelman, Hadas Stiebel-Kalish, Shay Tzur, Allen L Pimienta, Lily Bazak, Tuvia Bengal, Lior Cohen, Dan D Gaton, Concetta Bormans, Meytal Landau, Ran Kornowski, Mordechai Shohat, Doron M Behar.   

Abstract

We describe a Bedouin family with a novel autosomal recessive syndrome characterized by dilated cardiomyopathy and septo-optic dysplasia. Genetic analysis revealed a homozygous missense mutation in TAX1BP3, which encodes a small PDZ domain containing protein implicated in regulation of the Wnt/β-catenin signaling pathway, as the causative mutation. The mutation affects a conserved residue located at the core of TAX1BP3 binding pocket and is predicted to impair the nature of a crucial hydrophobic patch, thereby interrupting the structure and stability of the protein, and its ability to interact with other proteins. TAX1BP3 is highly expressed in heart and brain and consistent with the clinical findings observed in our patients; a knockdown of TAX1BP3 causes elongation defects, enlarged pericard, and enlarged head structures in zebrafish embryos. Thus, we describe a new genetic disorder that expands the monogenic cardiomyopathy disease spectrum and suggests that TAX1BP3 is essential for heart and brain development.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  Septo-optic dysplasia; TAX1BP3; cardiomyopathy; exome sequencing

Mesh:

Substances:

Year:  2015        PMID: 25645515     DOI: 10.1002/humu.22759

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing.

Authors:  Eyal Reinstein; Shay Tzur; Rony Cohen; Concetta Bormans; Doron M Behar
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

2.  Exome sequencing identified mutations in CASK and MYBPC3 as the cause of a complex dilated cardiomyopathy phenotype.

Authors:  Eyal Reinstein; Shay Tzur; Concetta Bormans; Doron M Behar
Journal:  Genet Res (Camb)       Date:  2016-05-13       Impact factor: 1.588

Review 3.  LITTLE FISH, BIG DATA: ZEBRAFISH AS A MODEL FOR CARDIOVASCULAR AND METABOLIC DISEASE.

Authors:  Philipp Gut; Sven Reischauer; Didier Y R Stainier; Rima Arnaout
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 4.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

5.  Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C.

Authors:  Eyal Reinstein; Ana Gutierrez-Fernandez; Shay Tzur; Concetta Bormans; Shai Marcu; Einav Tayeb-Fligelman; Chana Vinkler; Annick Raas-Rothschild; Dana Irge; Meytal Landau; Mordechai Shohat; Xose S Puente; Doron M Behar; Carlos Lopez-Otın
Journal:  Eur J Hum Genet       Date:  2016-09-07       Impact factor: 4.246

6.  Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.

Authors:  Lior Cohen; Shay Tzur; Nitza Goldenberg-Cohen; Concetta Bormans; Doron M Behar; Eyal Reinstein
Journal:  Genet Res (Camb)       Date:  2016-06-06       Impact factor: 1.588

7.  Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.

Authors:  Yue Zhao; Hong Cao; Yindi Song; Yue Feng; Xiaoxue Ding; Mingjie Pang; Yunmei Zhang; Hong Zhang; Jiahuan Ding; Xueshan Xia
Journal:  Int J Mol Med       Date:  2016-04-14       Impact factor: 4.101

8.  Septo-optic dysplasia caused by a novel FLNA splice site mutation: a case report.

Authors:  A Fernández-Marmiesse; M S Pérez-Poyato; A Fontalba; E Marco de Lucas; M T Martínez; M J Cabero Pérez; M L Couce
Journal:  BMC Med Genet       Date:  2019-06-24       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.